| CXSL2200027 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(3.3) | New Drug Application | 2022-01-20 | | Chengdu Institute of Biological Products Co Ltd | | | view |
| JYSB1800084 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2018-04-28 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Ltd;Pfizer Ireland Pharmaceuticals | Certificate Issued | 2018-12-18 | view |
| JYSB2300225 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2023-12-28 | | Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | | | view |
| JYSB2000107 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2020-04-11 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | Certificate Issued | 2020-04-28 | view |
| JYSZ2100004 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | License Renew | 2021-02-06 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | Certificate Issued | 2021-10-20 | view |
| CXSL1100069 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(6) | New Drug Application | 2011-12-01 | 玉溪沃森生物技术有限公司 | Yuxi Walvax Biotechnology Co Ltd | Certificate Issued | 2015-04-22 | view |
| CXSS2300013 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(3.3) | New Drug Application | 2023-03-16 | | Lanzhou Institute of Biological Products Co Ltd | | | view |
| JYSB1900070 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2019-04-03 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Ltd;Pfizer Ireland Pharmaceuticals | Certificate Issued | 2019-06-10 | view |
| JXSL2400209 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(3.1) | Import Drug Application | 2024-11-01 | | Pfizer Europe Ma Eeig;Pfizer Investment Co Ltd | | | view |
| JYSB2000432 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2020-09-04 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | Filed | 2020-09-15 | view |
| JYSB2300174 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2023-10-11 | | Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | | | view |
| JYSB2000084 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2020-03-19 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | Filed | 2020-03-26 | view |
| JYSB2500001 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2025-01-03 | | Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | | | view |
| CXSL2000316 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(2.2) | New Drug Application | 2020-11-06 | 江苏坤力生物制药有限责任公司；山东坤力生物制药有限责任公司 | | In Review | 2020-11-05 | view |
| JYSB2300021 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2023-02-07 | | Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | | | view |
| CYSB2400148 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2024-06-07 | | Yuxi Walvax Biotechnology Co Ltd | | | view |
| CXSL2000215 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(3.3) | New Drug Application | 2020-07-25 | 艾美卫信生物药业（浙江）有限公司 | Aimei Vacin BioPharm (Zhejiang) Co Ltd | In Review | 2020-07-24 | view |
| JYSB2200069 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2022-04-15 | | Pfizer Europe Ma Eeig;Pfizer Ireland Pharmaceuticals | | | view |
| JYSB1800034 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products | Supplementary Application | 2018-03-12 | 辉瑞投资有限公司 | Pfizer Investment Co Ltd;Pfizer Ltd;Pfizer Ireland Pharmaceuticals | Certificate Issued | 2018-06-29 | view |
| CXSS2400123 | 13价肺炎球菌多糖结合疫苗 | 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine | Injection | Biological Products(3.3) | New Drug Application | 2024-11-15 | | Aimei Vacin BioPharm (Zhejiang) Co Ltd | | | view |
